Pooled screening with next-generation gene editing tools.
CRISPR
CRISPR screen
Cell engineering
Gene editing
Gene regulation
Journal
Current opinion in biomedical engineering
ISSN: 2468-4511
Titre abrégé: Curr Opin Biomed Eng
Pays: England
ID NLM: 101704011
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
pmc-release:
01
12
2024
medline:
15
1
2024
pubmed:
15
1
2024
entrez:
15
1
2024
Statut:
ppublish
Résumé
Pooled screening creates a pool of cells with genetic variants, allowing for the simultaneous examination for changes in behavior or function. By selectively inducing mutations or perturbing expression, it enables scientists to systematically investigate the function of genes or genetic elements. Emerging gene editing tools, such as CRISPR, coupled with advances in sequencing and computational capabilities, provide growing opportunities to understand biological processes in humans, animals, and plants as well as to identify potential targets for therapeutic interventions and agricultural research. In this review, we highlight the recent advances of pooled screens using next-generation gene editing tools along with relevant challenges and describe potential future directions of this technology.
Identifiants
pubmed: 38222973
doi: 10.1016/j.cobme.2023.100479
pmc: PMC10786633
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
Declaration of interests The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: SC is a (co)founder of EvolveImmune Tx, Cellinfinity Bio, Chen Consulting, NumericGlobal, and Chen Tech, all unrelated to this study.